BrainScope Receives FDA Clearance for Multi-Modal, Multi-Parameter Concussion Assessment
New Concussion-Specific FDA Labeling Adds to Existing BrainScope Claims Complements Multi-Modal Technology Platform and Extensive Intellectual Property Portfolio To Address New Brain and Behavioral Health Conditions
{iframe}https://brainscope.com/media/2019/1/2/brainscope-receives-fda-clearance-for-multi-modal-multi-parameter-concussion-assessment{/iframe}